Division of Biomedical Sciences
Part of the Institute of Health Research and Innovation, the Division is based at the Centre for Health Science in Inverness. We conduct extensive research, primarily into the causes and consequences of diabetes, but also into a wide range of clinical conditions; most notably cardiovascular diseases, inflammatory diseases, and cancer. Led by Professor Ian Megson, the mission of the division is to undertake world class research into the causes and treatment of diabetes and the cardiovascular diseases that the condition precipitates.
The division also undertakes a range of contract research to support commercial entities of any size.
The division is home to the Free Radical Research Facility, and has research expertise in genetics and immunology, lipidomics and hosts the Active Health Exercise Lab. Explore these research areas in more detail by clicking on the below theme boxes:
Free radical research facility
Free radicals play crucial roles in human physiology and disease progression. Our focus is on measurement of a wide range of metabolites and markers in biological samples associated with oxidative stress and inflammation.
Active Health Exercise Lab
Combining expertise within the areas of physical activity, nutrition and biochemistry to help prevent and manage disease. Volunteer studies contribute directly to research-led developments in healthcare improvement.
Genetics and immunology
Groups in this department investigate the molecular and cellular basis of disease, including genetic, epigenetic, proteomic and immunological factors. This includes the study of schizophrenia, diabetes, heart disease and cancer (specifically, melanoma).
Mass Spectrometry And Bioinformatics Core Facility
Identifying the role of biomarkers in disease progression is crucial in helping to identify diseases early and to discover new, effective treatments. The team uses mass spectrometry as a powerful tool to allow simultaneous measurement of numerous chemical messengers involved in disease evolution; the very large datasets are then disentagled by complex bioinformatics and statistical analysis to inform clinical and laboratory research and drug discovery.
Nanotechnology is the application of materials at an extremely small scale. It is already preset in commercial products. we are focusing on how such systems may be applied to life sciences and healthcare.